Pharmaceutical Product Development, Inc. (NASDAQ:PPDI.DL)

CAPS Rating: No stars

The Company is a global contract research organization providing drug discovery and development services, post-approval expertise and compound partnering programs.

PPDI.DL News and Commentary

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top PPDI.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

A6EIntruder (< 20)
Submitted June 02, 2009

Once upon a time I worked for a CRO called Quintiles, which has since gone back to being a private company--and remains the biggest CRO in the field today. I was on their contract sales side, so I can't claim any clinical experience. However, even at… More

dexion10 (27.48)
Submitted October 25, 2007

The biz model of developing drugs internally will prove to be a drag on this company - the drugs they buy are drugs that other pharmas didn't want... for example their Statin drug and diabetes candidates are also rans.... nothing exceptional. Worse… More

PPDI.DL VS S&P 500 (SPY)

PPDI.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about PPDI.DL.

No one has written a Pitch for PPDI.DL stock yet. Tell us why you think PPDI.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in PPDI.DL.

No players have picked PPDI.DL yet. Tell us why you think PPDI.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackBBTCapMkts 83.53 7/14/2011 Outperform NS $27.98 +15.34% -17.88% +33.22 10/4/2011 @ $32.27 0 Comment
TrackZacks < 20 4/28/2011 Outperform 3M $31.05 -9.40% -3.12% -6.29 6/2/2011 @ $28.13 1 Comment
TrackGoldmanSach 79.31 7/26/2010 Outperform 5Y $26.30 +26.39% +14.12% +12.27 12/6/2011 @ $33.24 1 Comment
TrackJefferies 85.02 3/4/2010 Outperform NS $19.61 +69.53% +12.25% +57.29 12/6/2011 @ $33.24 0 Comment
TrackRWBaird 89.83 10/13/2009 Outperform NS $21.00 +58.26% +17.13% +41.13 12/6/2011 @ $33.24 0 Comment
TrackStandpoint 40.80 7/31/2009 Outperform NS $18.98 +34.83% +23.04% +11.79 5/3/2010 @ $25.59 0 Comment
TrackDeutscheSec 89.78 7/10/2009 Outperform NS $21.01 +7.41% +29.35% -21.95 1/7/2010 @ $22.57 0 Comment
TrackBarclaysCap 91.23 1/13/2009 Outperform NS $21.84 +52.23% +45.53% +6.69 12/6/2011 @ $33.24 0 Comment
TrackPiperJaff 86.54 12/23/2008 Outperform NS $25.48 +30.45% +44.20% -13.75 12/6/2011 @ $33.24 0 Comment
TrackRWBaird 89.83 10/13/2008 Outperform NS $31.76 -40.08% +0.84% -40.91 7/22/2009 @ $19.03 0 Comment
TrackRWBaird 89.83 7/24/2008 Outperform NS $40.08 +8.58% -0.99% +9.57 9/9/2008 @ $43.52 0 Comment
TrackLadenburg < 20 7/2/2008 Outperform NS $42.14 -44.14% -34.09% -10.05 4/16/2009 @ $23.54 0 Comment
TrackLehmanBros < 20 1/8/2008 Outperform NS $39.04 -14.86% -11.60% -3.26 12/6/2011 @ $33.24 0 Comment
TrackEveillard 94.16 9/30/2007 Outperform NS $30.93 +7.47% -17.28% +24.75 12/6/2011 @ $33.24 1 Comment
TrackWhitman < 20 9/30/2007 Outperform NS $35.19 +16.95% -14.86% +31.81 8/29/2008 @ $41.16 1 Comment
TrackFBRCapitalM 89.65 12/12/2006 Outperform NS $31.72 +35.11% -11.57% +46.67 7/10/2008 @ $42.86 0 Comment
TrackBofASec 94.39 11/3/2006 Outperform NS $27.46 +21.05% -8.05% +29.10 12/6/2011 @ $33.24 0 Comment
TrackBearStearns < 20 10/17/2006 Outperform NS $30.99 +7.28% -7.42% +14.70 12/6/2011 @ $33.24 0 Comment
TrackUBS 93.16 10/6/2006 Outperform NS $30.58 +8.71% -6.41% +15.12 12/6/2011 @ $33.24 0 Comment
TrackJimCramer 84.37 4/21/2006 Outperform 3W $32.15 +3.38% -4.14% +7.52 12/6/2011 @ $33.24 0 Comment

Featured Broker Partners